actiniumpharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Actinium Pharmaceuticals, Inc. |
| Description | Home About Overview Management Team Board of Directors Partners Product Pipeline Overview Iomab-B Actimab-A Actimab-A NCI CRADA Iomab-ACT for Gene & Cell |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 54.208.101.55 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
actiniumpharma.com Valuation
|
US$25,110,265
Last updated: 2023-04-30 16:18:30
actiniumpharma.com has Semrush global rank of 421,513. actiniumpharma.com has an estimated worth of US$ 25,110,265, based on its estimated Ads revenue. actiniumpharma.com receives approximately 2,897,339 unique visitors each day. Its web server is located in United States, with IP address 54.208.101.55. According to SiteAdvisor, actiniumpharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$25,110,265 |
| Daily Ads Revenue | US$23,179 |
| Monthly Ads Revenue | US$695,362 |
| Yearly Ads Revenue | US$8,344,335 |
| Daily Unique Visitors | 193,156 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| actiniumpharma.com. | A | 299 | IP: 54.208.101.55 |
| actiniumpharma.com. | A | 299 | IP: 174.129.30.187 |
| actiniumpharma.com. | NS | 86400 | NS Record: ns-248.awsdns-31.com. |
| actiniumpharma.com. | NS | 86400 | NS Record: ns-727.awsdns-26.net. |
| actiniumpharma.com. | NS | 86400 | NS Record: ns-1046.awsdns-02.org. |
| actiniumpharma.com. | NS | 86400 | NS Record: ns-1944.awsdns-51.co.uk. |
| actiniumpharma.com. | MX | 300 | MX Record: 0 mx.humblemonkey.com. |
| actiniumpharma.com. | TXT | 300 | TXT Record: MS=ms72557187 |
| actiniumpharma.com. | TXT | 300 | TXT Record: TG=gfe873 |
| actiniumpharma.com. | TXT | 300 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
| actiniumpharma.com. | TXT | 300 | TXT Record: MS=513ACFEBCCB7C5010230DCB19F8B5F8F071732FE |
HtmlToTextCheckTime:2023-04-30 16:18:30
| Home About Overview Management Team Board of Directors Partners Product Pipeline Overview Iomab-B Actimab-A Actimab-A NCI CRADA Iomab-ACT for Gene & Cell Therapy Conditioning Clinical Trial Information Publications AWE Technology Investors Investor Relations Overview News / Events Press Releases IR Calendar Video Gallery Email Alerts Company Info Profile Presentations & Webinars Contacts Analyst Coverage FAQ Stock Data Quote Charts Historical Data SEC Filings All SEC Filings Annual Reports Quarterly Reports Governance Board of Directors Board Committees Governance Documents Careers Contact Targeted Radiotherapies for Patients with Unmet Needs Actinium is developing a pipeline of Antibody Radiation Conjugates for targeted conditioning and combination therapies Positive Top-line Results from Pivotal Phase 3 SIERRA Trial, Iomab‑B Met Primary Endpoint p<0.0001 Learn More SIERRA: Pivotal Phase 3 Clinical Trial of Iomab-B Actimab-A: CD33 targeting, mutation agnostic r/r AML therapeutic |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Sat, 23 Oct 2021 10:48:34 GMT Server: Apache Location: http://www.actiniumpharma.com/ Content-Type: text/html; charset=UTF-8 HTTP/1.1 302 Moved Temporarily Content-Type: text/html; charset=UTF-8 Date: Sat, 23 Oct 2021 10:48:34 GMT Location: https://www.actiniumpharma.com/ Server: Apache Connection: keep-alive HTTP/1.1 200 OK Date: Sat, 23 Oct 2021 10:48:34 GMT Server: Apache Content-Type: text/html; charset=UTF-8 |
actiniumpharma.com Whois Information
Domain Name: ACTINIUMPHARMA.COM Registry Domain ID: 1832408216_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2020-10-26T13:48:59Z Creation Date: 2013-10-24T20:54:03Z Registry Expiry Date: 2025-10-24T20:54:03Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1046.AWSDNS-02.ORG Name Server: NS-1944.AWSDNS-51.CO.UK Name Server: NS-248.AWSDNS-31.COM Name Server: NS-727.AWSDNS-26.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T21:48:36Z <<< |